Thursday, February 7, 2013

Nature Biotechnology Contents: Volume 31 pp 85 - 176

Nature Biotechnology


Advertisement

RNA-Seq just went from complicated to compatible. Expression Analysis will provide your data in a format you are used to -- 100% microarray compatible format. Now you can have your data and use it too! EA will help you detect 2x more differentially expressed transcripts, novel isoforms and SNVs and can achieve >97% alignment. 919-405-2248 * 866-293-6094

TABLE OF CONTENTS

February 2013 Volume 31, Issue 2

Editorial
News
Bioentrepreneur
Opinion and Comment
Features
News and Views
Computational Biology
Research
Careers and Recruitment

Advertisement

Reichert surface plasmon resonance (SPR) systems drive research - from discovery to development to publication.
For a limited time Reichert scientists will provide: FREE startup, FREE training, FREE fluidics kit, with the purchase of any SPR system. A $4000 value!
Start this label-free interaction analysis in your lab for ultra-sensitive, data-rich information.
ReichertSPR.com


Subscribe
 
Facebook
 
RSS
 
Recommend to library
 
Twitter
 
Advertisement

BIOPHARMA DEALMAKERS
BIOPHARMA DEALMAKERSCompany Profiles and Partnering Opportunities


 
Advertisement
Nature Biotechnology
Focus on DNA Sequencing Technology

Performance gains and falling costs have fueled diverse applications of high-throughput DNA sequencing. This focus issue summarizes the current status of these technologies as applied to life sciences and medical research.

Click here to access the Focus!

Produced with support from:
 

Editorial

Top

Dishing out cancer treatment   p85
doi:10.1038/nbt.2516
Despite their limitations, in vitro assays are a simple means for assessing the drug sensitivity of a patient's cancer. After consulting experts in the community, we think such assays deserve a second look.

News

Top

Amgen punts on deCODE's genetics know-how   pp87 - 88
Cormac Sheridan
doi:10.1038/nbt0213-87

Chinese investors tap US biotechs   p88
Hepeng Jia
doi:10.1038/nbt0213-88

First novel anti-tuberculosis drug in 40 years   pp89 - 91
Randy Osborne
doi:10.1038/nbt0213-89

Citizen microbiome   p90
Moheb Costandi
doi:10.1038/nbt0213-90a

Gilead widens cancer focus   p90
Malorye Allison
doi:10.1038/nbt0213-90b

Isis inks two antisense deals   p91
Malorye Allison
doi:10.1038/nbt0213-91a

Forty fight rust and rot   p91
Lucas Laursen
doi:10.1038/nbt0213-91b

Exelixis debuts in rare cancer   p92
Malini Guha
doi:10.1038/nbt0213-92a

First drug for short-bowel   p92
Emma Dorey
doi:10.1038/nbt0213-92b

Startups, inventors cheer European unified patent   pp92 - 93
Nuala Moran
doi:10.1038/nbt0213-92c

Egg-free flu vaccines   p93
Jeffrey L Fox
doi:10.1038/nbt0213-93a

UK science's Christmas gift   p93
Barbara Casassus
doi:10.1038/nbt0213-93b

BioTime acquires Geron's stem cell program   p94
Vicki Brower
doi:10.1038/nbt0213-94a

Brustle patent holds up in Germany   p94
Nuala Moran
doi:10.1038/nbt0213-94b

Industry backs biocatalysis for greener manufacturing   pp95 - 96
Susan Aldridge
doi:10.1038/nbt0213-95

All conflicts of interest in one site   p97
Jeffrey L Fox
doi:10.1038/nbt0213-97a

Around the world in a month   p97
doi:10.1038/nbt0213-97b

Editor's Pick

Inovio   p98
Jennifer Rohn
doi:10.1038/nbt0213-98
A Pennsylvania company hopes to turn synthetic DNA vaccines into rapid response agents against flu epidemics and cancer.

Data Page

2012—Bullish for big biotech   p99
Walter Yang
doi:10.1038/nbt.2504

News Feature

Fresh from the biotech pipeline—2012   pp100 - 103
Randy Osborne
doi:10.1038/nbt.2498
FDA approvals hit a new high mark in 2012, with a December flurry of approvals. Orphan and fast-track drugs showed strong in the list. Randy Osborne reports.

Bioentrepreneur

Top
Building a business

Giving voice to India's entrepreneurs   pp104 - 107
Gayatri Saberwal
doi:10.1038/nbt.2493

Opinion and Comment

Top
Correspondence

Prize-based contests can provide solutions to computational biology problems   pp108 - 111
Karim R Lakhani, Kevin J Boudreau, Po-Ru Loh, Lars Backstrom, Carliss Baldwin, Eric Lonstein, Mike Lydon, Alan MacCormack, Ramy A Arnaout and Eva C Guinan
doi:10.1038/nbt.2495

Commercialized transgenic traits, maize productivity and yield risk   pp111 - 114
Guanming Shi, Jean-Paul Chavas and Joseph Lauer
doi:10.1038/nbt.2496

Commentary

Liquid refreshment   p115
Christopher Scott
doi:10.1038/nbt.2481
Compared with the long time horizons and diminished returns of traditional antibody startups, Ablexis gave investors a deal they couldn't refuse.

Features

Top
Patents

Intellectual property rights and user facility agreements   pp116 - 117
Francis Hane
doi:10.1038/nbt.2494
Scientific collaborations can produce results greater than the sum of their parts, but determining who owns the IP rights to scientific results is of prime importance.

Recent patent applications in polyethylene glycosylation   p118
doi:10.1038/nbt.2513

News and Views

Top

Epigenetic trigger for tomato ripening   pp119 - 120
Joseph R Ecker
doi:10.1038/nbt.2497
The maturation of tomato fruits is accompanied by widespread reprogramming of the epigenome.

See also: Research by Zhong et al.

Discovery of antibiotic adjuvants   pp120 - 122
Maya A Farha and Eric D Brown
doi:10.1038/nbt.2500
Modeling the production of reactive oxygen species in bacteria reveals targets for adjuvants that boost antibiotic activity.

See also: Research by Brynildsen et al.

RESEARCH HIGHLIGHTS   p122
doi:10.1038/nbt.2506

Pig genomics for biomedicine   pp122 - 124
Randall S Prather
doi:10.1038/nbt.2490
The newly released swine genome assembly will aid research on disease models and xenotransplantation.

Goat genome sequence by optical mapping   p123
H Craig Mak
doi:10.1038/nbt.2502

See also: Research by Dong et al.

Membrane channels built from DNA   p125
Markus Elsner
doi:10.1038/nbt.2499

Biotechnology
JOBS of the week
Postdoctoral, Physical / Chemical
Cornell University
Postdoctoral Researcher in Organic Synthesis
Uppsala University
Postdoctoral fellow in Nanomedicine
Ian Wark Research Institute


Biotechnology Engineer
SymbioTEK
More Science jobs from
Biotechnology
EVENT
Plant Genomes & Biotechnology: from Genes to Networks
December 4-7, 2013
Cold Spring Harbor, US
More science events from

Computational Biology

Top
Analysis

Evaluation of methods for modeling transcription factor sequence specificity   pp126 - 134
Matthew T Weirauch, Atina Cote, Raquel Norel, Matti Annala, Yue Zhao, Todd R Riley, Julio Saez-Rodriguez, Thomas Cokelaer, Anastasia Vedenko, Shaheynoor Talukder, Phaedra Agius, Aaron Arvey, Philipp Bucher, Curtis G Callan Jr, Cheng Wei Chang, Chien-Yu Chen, Yong-Syuan Chen, Yu-Wei Chu, Jan Grau, Ivo Grosse, Vidhya Jagannathan, Jens Keilwagen, Szymon M Kielbasa, Justin B Kinney, Holger Klein, Miron B Kursa, Harri Lahdesmaki, Kirsti Laurila, Chengwei Lei, Christina Leslie, Chaim Linhart, Anand Murugan, Alena Mysickova, William Stafford Noble, Matti Nykter, Yaron Orenstein, Stefan Posch, Jianhua Ruan, Witold R Rudnicki, Christoph D Schmid, Ron Shamir, Wing-Kin Sung, Martin Vingron, Zhizhuo Zhang, DREAM5 Consortium:  Phaedra Agius, Aaron Arvey, Philipp Bucher, Curtis G Callan Jr, Cheng Wei Chang, Chien-Yu Chen, Yong-Syuan Chen, Yu-Wei Chu, Jan Grau, Ivo Grosse, Vidhya Jagannathan, Jens Keilwagen, Szymon M Kielbasa, Justin B Kinney, Holger Klein, Miron B Kursa, Harri Lahdesmaki, Kirsti Laurila, Chengwei Lei, Christina Leslie, Chaim Linhart, Anand Murugan, Alena Mysickova, William Stafford Noble, Matti Nykter, Yaron Orenstein, Stefan Posch, Jianhua Ruan, Witold R Rudnicki, Christoph D Schmid, Ron Shamir, Wing-Kin Sung, Martin Vingron and Zhizhuo Zhang Harmen J Bussemaker, Quaid D Morris, Martha L Bulyk, Gustavo Stolovitzky and Timothy R Hughes
doi:10.1038/nbt.2486
The most comprehensive analysis to date of models of transcription-factor binding specificity reveals the best methods for predicting in vivo binding from in vitro data.

Research

Top
Articles

Sequencing and automated whole-genome optical mapping of the genome of a domestic goat (Capra hircus) OPEN   pp135 - 141
Yang Dong, Min Xie, Yu Jiang, Nianqing Xiao, Xiaoyong Du, Wenguang Zhang, Gwenola Tosser-Klopp, Jinhuan Wang, Shuang Yang, Jie Liang, Wenbin Chen, Jing Chen, Peng Zeng, Yong Hou, Chao Bian, Shengkai Pan, Yuxiang Li, Xin Liu, Wenliang Wang, Bertrand Servin, Brian Sayre, Bin Zhu, Deacon Sweeney, Rich Moore, Wenhui Nie, Yongyi Shen, Ruoping Zhao, Guojie Zhang, Jinquan Li, Thomas Faraut, James Womack, Yaping Zhang, James Kijas, Noelle Cockett, Xun Xu, Shuhong Zhao, Jun Wang and Wen Wang
doi:10.1038/nbt.2478
An instrument for whole-genome optical mapping is used to assemble the genome of the domestic goat into super-long scaffolds.

See also: News and Views by Mak

Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis   pp142 - 147
Yun Liu, Martin J Aryee, Leonid Padyukov, M Daniele Fallin, Espen Hesselberg, Arni Runarsson, Lovisa Reinius, Nathalie Acevedo, Margaret Taub, Marcus Ronninger, Klementy Shchetynsky, Annika Scheynius, Juha Kere, Lars Alfredsson, Lars Klareskog, Tomas J Ekstrom and Andrew P Feinberg
doi:10.1038/nbt.2487
Liu et al. use mediation analysis to find changes in DNA methylation that mediate the genetic risk for rheumatoid arthritis.

Targeted zwitterionic near-infrared fluorophores for improved optical imaging   pp148 - 153
Hak Soo Choi, Summer L Gibbs, Jeong Heon Lee, Soon Hee Kim, Yoshitomo Ashitate, Fangbing Liu, Hoon Hyun, GwangLi Park, Yang Xie, Soochan Bae, Maged Henary and John V Frangioni
doi:10.1038/nbt.2468
Diagnostic and surgical procedures that rely on optical imaging are improved by using near-infrared fluorescent probes with low background signal.

Single-base resolution methylomes of tomato fruit development reveal epigenome modifications associated with ripening   pp154 - 159
Silin Zhong, Zhangjun Fei, Yun-Ru Chen, Yi Zheng, Mingyun Huang, Julia Vrebalov, Ryan McQuinn, Nigel Gapper, Bao Liu, Jenny Xiang, Ying Shao and James J Giovannoni
doi:10.1038/nbt.2462
Whole-genome bisulfite sequencing reveals that global reprogramming of the epigenome occurs during the maturation of tomato fruits, potentially identifying new targets for breeders.

See also: News and Views by Ecker

Letters

Potentiating antibacterial activity by predictably enhancing endogenous microbial ROS production   pp160 - 165
Mark P Brynildsen, Jonathan A Winkler, Catherine S Spina, I Cody MacDonald and James J Collins
doi:10.1038/nbt.2458
The first global metabolic models that incorporate reactive oxygen species in E. coli reveal targets for potentiating the action of antibacterials.

See also: News and Views by Farha & Brown

High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire   pp166 - 169
Brandon J DeKosky, Gregory C Ippolito, Ryan P Deschner, Jason J Lavinder, Yariv Wine, Brandon M Rawlings, Navin Varadarajan, Claudia Giesecke, Thomas Dorner, Sarah F Andrews, Patrick C Wilson, Scott P Hunicke-Smith, C Grant Willson, Andrew D Ellington and George Georgiou
doi:10.1038/nbt.2492
A new method facilitates high-throughput sequencing of the repertoire of immunoglobulin heavy-light chain pairs in human B cells.

Metabolic engineering of Escherichia coli using synthetic small regulatory RNAs   pp170 - 174
Dokyun Na, Seung Min Yoo, Hannah Chung, Hyegwon Park, Jin Hwan Park and Sang Yup Lee
doi:10.1038/nbt.2461
Synthetic small RNAs are designed for use in metabolic pathway optimization in bacteria.

Careers and Recruitment

Top

Fourth-quarter biotech job picture   p175
Michael Francisco
doi:10.1038/nbt.2505

People

People   p176
doi:10.1038/nbt.2511

Top
Advertisement
Epigenetics: Why histone modifications matter in health and disease  
February 26
10am EST | 3pm GMT

Histones are an integral part of chromatin as they make up the 'protein spools' DNA is wound around. Two prominent speakers will explore one of the key questions in chromatin biology: how the language of post translational modifications on histones influences gene expression. 

Register for FREE   
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant)

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our customer feedback department

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group

No comments: